Results 221 to 226 of about 32,260 (226)
Some of the next articles are maybe not open access.
Journal of Cellular Biochemistry, 2018
Osteoclasts are highly differentiated terminal cells formed by fusion of hematopoietic stem cells. Previously, osteoprotegerin (OPG) inhibit osteoclast differentiation and bone resorption by blocking receptor activator of nuclear factor‐κB ligand (RANKL)
Xishuai Tong +9 more
semanticscholar +1 more source
Osteoclasts are highly differentiated terminal cells formed by fusion of hematopoietic stem cells. Previously, osteoprotegerin (OPG) inhibit osteoclast differentiation and bone resorption by blocking receptor activator of nuclear factor‐κB ligand (RANKL)
Xishuai Tong +9 more
semanticscholar +1 more source
Current Vascular Pharmacology, 2019
BACKGROUND Osteoprotegerin and osteopontin have recently emerged as key factors in both vascular remodelling and atherosclerosis progression. Interleukin-6 (IL-6) is an inflammatory cytokine with a key role in atherosclerosis.
K. Maniatis +9 more
semanticscholar +1 more source
BACKGROUND Osteoprotegerin and osteopontin have recently emerged as key factors in both vascular remodelling and atherosclerosis progression. Interleukin-6 (IL-6) is an inflammatory cytokine with a key role in atherosclerosis.
K. Maniatis +9 more
semanticscholar +1 more source

